OM

Opaleye Management Portfolio holdings

AUM $707M
1-Year Est. Return 67.55%
This Quarter Est. Return
1 Year Est. Return
+67.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$600M
AUM Growth
+$162M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$17.2M
2
+$16.4M
3
+$13.7M
4
DNA icon
Ginkgo Bioworks
DNA
+$6.68M
5
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$3.56M

Top Sells

1
+$10.5M
2
+$7.26M
3
+$7.19M
4
CYTK icon
Cytokinetics
CYTK
+$6.5M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.88M

Sector Composition

1 Healthcare 98.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
– –
-475,000
52
– –
-714,960
53
– –
-915,000
54
– –
-1,190,000
55
– –
-16,500
1 2
3